Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
CHEMBIO DIAGNOSTICS, INC.
| Metric | CHEMBIO DIAGNOSTICS, INC. Healthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $50M |
| Net income (latest) | −$23M |
| Operating margin | −47.7% |
| Net margin | −47.0% |
| Return on equity | −130.9% |
| Return on assets | −37.2% |
| Return on capital (ROCE) | −101.4% |
| Debt / equity | 2.52× |
| Revenue growth (YoY) | 3.6% |
| Altman Z″ (distress) | -9.20 |
| Accruals / assets | −16.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.